Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : GX-30
Therapeutic Area : Undisclosed
Study Phase : Phase I/ Phase II
Recipient : Genexine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 08, 2017
Lead Product(s) : GX-30
Therapeutic Area : Undisclosed
Highest Development Status : Phase I/ Phase II
Recipient : Genexine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : CDFR0812
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 08, 2015
Lead Product(s) : CDFR0812
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : CDFR0612
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 02, 2014
Lead Product(s) : CDFR0612
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 07, 2014
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : CTC Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomipramine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of PED-1 in Male Patients With Premature Ejaculation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 23, 2011
Lead Product(s) : Clomipramine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GC1113
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 02, 2011
Lead Product(s) : GC1113
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pegfilgrastim
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
GCPGC in Chemotherapy-induced Neutropenia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
April 05, 2011
Lead Product(s) : Pegfilgrastim
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Immunoglobulin G
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Inapplicable
March 15, 2011
Lead Product(s) : Immunoglobulin G
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : Green Cross Lab Cell
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomipramine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 16, 2010
Lead Product(s) : Clomipramine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
